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1, INTRODUCTION 
RNaoc is a valuable system for studying the general 
aspects ofstru~ture and catalysis in proteins [1,2]. Fur- 
thermore, some extracellular homologs of RNase A 
have interesting biological properties [3a,b,c and 41 
and, together with extracellular RNA as their substrate 
[5a,b] may play a role in the regulation of cell growth 
[6a,b]. Also, an understanding of the mechanism by 
which RNase catalyzes the hydrolysis of phosphodiesrer 
bonds can guide efforts to develop ‘catalytic antiscnse’ 
oligonucleotide analogs, analogs that are stable to 
chemical and biological degradation, penetrate 
biological barriers, bind to complementary mRNA and, 
via attached functional groups, catalyze the hydrolysis 
of the bound mRNA (“la,b,c]. Such oligonucleotide 
analogs may be able to disrupt the expression of specific 
mRNA molecules without the assistance of RNase H 
PJwl. 
In the reaction catalyzed by RNase A, roles for 
His-12 and His-l 19 as general acid and general base 
catalysts are well established [11. However, model 
studies have shown that simple molecules bearing two 
imidazole rings are far poorer catalysts than RNase A 
itself for the hydrolysis of RNA 181. Thus, other 
residues in the active site of RNase A must be important 
for catalysis, both in the enzyme, and in many 
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molceulcs designed to mimic the catalytic properties of 
rhc enzyme. 
Two candidates for such residues are Lysm41 and 
Asp-121 [9]. Chemical modification of Lys-41 (see [I] 
for a review) invariably yields an enzyme with greatly 
reduced catalytic power, although the modifications 
often appear to differently affect the rates of various 
steps in the catalytic ycle (in particular, the formation 
and the hydrolysis of the 2’,3’-cyclic phosphate in- 
termediate) [IO] and the rates at which different 
substrates are processed [I la,b]. Crystallographic 
studies have shown that when RNase is bound to the 
vanadatc omplex of uridine, Lys-41 appears to interact 
with the negatively charged vanadate oxygen [12]. 
These studies imply that the positive charge of the e- 
amino group of Lys-41 stabilizes the negatively charged 
oxygen on the pentacoordinate phosphate in the transi- 
tion state. 
Catalytic roles for Asp-121 are less clear, although 
the residue may form hydrogen bonds with His-119, 
perhaps acting in a ‘charge relay’ fashion [13]. When 
the C-terminal residues of RNase (residues 121-124) are 
removed by proteolysis, only 0.5% to 4070 of the 
catalytic activity towards various substrates i retained 
[14,lSl; further digestion removes all traces of catalytic 
activity. However, catalytic activity can be restored by 
adding synthetic peptides extending from residues 
Ill-124 [16] or residues 115-124 [IS], peptides that 
form non-covalent complexes with the digested RNase 
protein. 
Of course, the interpretation of results obtained from 
chemical modifications that introduce bulky substi- 
tuents into the proMn OS frt~wr rkonstructed non= 
covalent complexes between RNase A and synthetic 
peptides are often complicated by issues not directly 
Voiumc 281, number I ,% 
relating ta the eontributian to catalysis af the midc 
chninn thenrseluar~ This ia, rrf cairse, prscincly the Xart 
of prablsm well ouitcd for nite&eetcd milrupmtsis 
studies, We rcparr here the behnviar erfmurant fkrma of 
RNrrre A where Lyr41 is replaced by bra nnd &pl:!l 
is replaced by Cllrr, 
Gen$r r0r r4e nuumr dcreribed lrerc worr prcprctl by modul.rr 
mutagrncsla of I nynlhclic gone coding for RNnsc A, rlcsrribcd 
clrewhcrc 117). e)ll~onuelculidcr were xyn~heslxod on OR Applkd 
Diorys[cms model 3110h xynlhcsincr using phusphornmldite ehemlrrry 
and purified either by poiynrryiamitle gel el~~rophorcslx (PACiB) on 
16Oi* gels, or, in lhc cast of sharl 0li~anuclcolid~s, by rhin lnycr 
chromatography, Both mrlivr and mulrnr prokin% wcrc exprcrncd in 
C. co/i behind Ihc lembdn promoter, using n modification [IS) of IAC 
exprcsslon system dcreribcd prcvlously [ 19). All cxprsrscd RN~ircs 
wcrc purified as described in [hssc previous pqxrs. The pro~als 
yirldcd ?-IS mg/ml ol RNUXF A and its murams, nil homogcneoux by 
PAGE (Fig. I), bath denaturing und native. 
Kinetic5 were pcrrormed using ckhcr uridylyL(3 -5’).adenosinc! 
(UpA, Sigmr) or cytidinc-2’ ,3 ‘-cyclic phoaph:\rr (C> p, Siam@ na 
subslmtc. The rate of hydrolysis of Uph (I 5-?fKl &l) m XT was 
mearurcd in sodium RCCIOIC buffer (pi-i 5.0, IO0 mM) by coupling lhr 
reaction 10 the dci\minnrion al ndonosine by adcnosinc dcaminrrc 
(Sigma), which wtls followed nl 275 nm accardinp to published pro. 
crdurts (20). The rate of hydrolysis of’C > p nl 37Y in Trir-HCl buf- 
fer (pM 7.1, IO0 mM) wns measured by UV rpcclroscopy at 294 nm 
according 10 published proccdurcs [21), The conccmrntion of cnsymc 
was mcaourcd either by measuring its absorbance aI 280 nm (abror- 
bancc of a 1% solution is 7.3; alrcrnativcly, 1st 278 nm, ~lre molar es- 
dnction coefficient is 9,800) or by the Rio-Rnd modificnlion of the 
Rradford assay 122). 
3. RESULTS AND DISCUSSION 
With UpA as a substrate, native RNase A (expressed 
in E. co10 has a ken, of 1455 f 67 s- I, a Knl of 323 f 52 
FM, and a kcnrlKM of 4.4 x 10” M * ’ - s- 1 (determined 
from 7 independent kinetic runs). Commercial RNasc A 
(from Boehringer-Mannheim) has a similar kcnr/#M of 
4.8 x 10”. Replacing Lys-41 by an Arg yields a mutant 
(K4lR) of RNase A that has a kcat of 309~ 3 s-l, a KM 
of 355&70@, and a k,,JKM of 8.5x 10J M-l ‘s-l, 
Replacing both residues yields a dauble mutant 
(K41 R Dl2lE) with a kqrl af 1636 J- ‘, a Kbr sf 
218*62 ICM, antl a k&J&! aT 6x IO- Mm’ ’ 9’; ‘, 
measured with Uph in two independent kinetic WIB, nt 
nn enzyme concentration of 32.7 nM. 
Assays were also run with C>p II substrate at two 
different concentrations. Data from these assays are 
collected in Table I, where ill can be seen that rc#ulra ob- 
taincd were quantitntivcly similar IO rhase cabtained 
with UpA as substrate. 
These results show that the side chain of Lys-41 is 
quite important for catalytic activity. This conclusion 
can be compared to that recently reported by Miranda 
and Pcrsko, who prepared a muranr of rat ribonuclcase 
where Lys-41 was replaced by Ala [23], This mutant is 
reported to have 2% of the earalytic aeriviry of RNasc 
A using RNA as substrate, and 3.4% the catalytic ac- 
tivity of RNasc A using U > p as substrate [23j, These 
resutts are remarkably consistent with the results 
reporrcd here for the K41 R mutant, despite the fecr that 
the new residue (Arg vs. Ala), the substrate (UpA and 
C>p vs. U>P), and the ‘context’ (bovine RNase ver- 
sus rat RNasc) are all different in these two studies, Fur- 
ther, the fact that comparable activities are observed 
when Lys-41 is replaced by Arg (a conservative substitu- 
rion where the positive charge is retained) and by Ala 
(where rhe positive charge is lost) suggests that in our 
mutant, the side chain of Arg-41 does not contribute to 
catalysis, even though it retains a positive charge., 
The smaller impact of the substitution at position 121 
suggests that Asp-121 is not as intimately involved in 
catalysis as is Lys-41. Our kinetic results can be com- 
pared with the results obtained with the ‘semi-synthetic’ 
proteins formed by non-covalent complexation between 
RNase l-120 and 6”’ f-,:ious synthetic peptides [15,16]. 
With Asn-121 in the peptide, the turnover catalyzed by 
the complex is 4.5% of the catalytic activity of the com- 
Fig. 1. Gel of mutants of RNase used in this work: lane 1, RNasc A 
(Boehringer-Mannheim; lane 2, K41 R; lane 3, K41R D121E; lane 4, 
D121E; lanes 5 and 6, RNase A (expressed in E. co/i), 
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Table I 
Catalytic activity of mutant RNases with 2’.3’-cyclic-CMP as 
substrate* 
[C>PI 
Mutant 100 ELM 
K41R < to/‘0 
Dl2lE 17% 
K41R D121E 3% 
*Expressed as % relative to wild type. 
400 $vl 
2% 
16% 
2% 
Volume ~1.  numt~r i.= FEBS 
plex reconstructed with a peptld¢ containing Asp at 
position 12i (with C> p as substrat¢); the decrease in 
turnover is pr imari ly in catalytic activity, not in the 
abi l i ty of  enzyme to bind substrate [16], In contrast. 
when the pepl ide complementing the t runcated RNase 
1-120 contains a Glu as position 121, the V,.~ is 64% 
and the KM 1~0% that o f  the analogous reconstruction 
with Asp-121 (whh CpA as substrate) [r~], 
From a structura l  s tandpo int ,  these results arc  dir ,  
f icult to interpret without  crysta l lographic  dam on  the 
mutants themselves. Nevertheless, the loop containing 
Lys-41 is known f rom crysta l lograph ic  work to undergo 
a large conformat iona l  change when substrate binds 
[24], a conformat iona[  change that is believed to deliver 
the  side chain of  Lys-4 i  to the posit ion where its pro- 
tonated  amine group can best interact  with the negative.  
ly charged pentacoord inated  phosphate group in the 
t rans i t ion state. It is conce ivable  that the same confor -  
mat iona l  change does not  del iver the posit ively charged 
group in the side chain of argininc to  the same posit ion,  
gwen the d i f ferent  geometry  o f  an arginine side chain, 
It would  be interest ing to learn whether compensat ing 
mutat ions  in this loop wou ld  restore some or all act ivity 
to the K4 IR  mutant .  
Interest ingly,  in t roduc ing the D I21E  mutat ion into a 
RNAso  mutant in which  Lys-41 has already been replac- 
ed by an Arg  apparent ly  does not  lower the catalyt ic  ac- 
t iv i ty further (Tab le  I), Indeed,  a l though the measured 
rates are quite low and therefore imprecise, it appears  
that  the doub le  mutant  has a higher activity than the 
K4 IR mutant  itself  under  at Ieast some assa~ condit ions 
(e,g. [C>p] = I00 ~M), It is, of course, possible that 
an alternative mechanism is operating in the double mu- 
tant and future work wil l  be d i rected in part to explor-  
ing this possibi l i ty.  
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